This study reports an adaptive experience of pigmented scar treatment management with different characteristics. It is complicated to define a single solution for all the patients. For this reason, we report a multi-modal approach combining CO2 laser, Q-switched lasers (QSL), and dye laser to adapt to every different patient clinical situation.
Materials and Methods:
Thirty patients were enrolled to treat pigmented scars. Twenty patients presented scars with exogenous pigment (such as traumatic tattoos) and 10 with endogenous pigment (hyperpigmentation cases). A combination of CO2 laser, QSL, and dye laser was used. The number of treatment sessions performed for each laser, or their combination was as follow: For keloid scars from tattoo: 1–4 combined treatment sessions with QS and dye lasers; 3–4 combined treatment sessions with dye and CO2 laser;1–4 treatment sessions with QS followed by dye laser; for asphalt traumatic tattoo: 2–3 treatment sessions with QS; for surgical hypertrophic scars: 2–3 combined treatment sessions of QS and CO2 laser; for burn scars (due to asphalt contact) and hyperpigmentation: one treatment session with QS followed by CO2 laser. Six months after the final treatment, the patient’s scar improvement was evaluated compared with baseline (T0) using a five-point Global Aesthetic Improvement Scale (GAIS).
Results:
Regardless of the type of lesion and treatment, the whole population of the study showed satisfactory clinical results. The GAIS mean value was 3.3 ± 0.6. Specifically, 47% of the patients reported good results while 43% had excellent ones. No serious side effects were observed.
Conclusions:
Our results suggest that a combination of CO2, dye, and Nd:YAG lasers is a feasible strategy for treating scars, reducing the pigmentary, fibrotic, and vascular components.
CenQ, GuY, LuoL, et al.Comparative effectiveness of 755-nm Picosecond Laser, 755- and 532-nm Nanosecond Lasers for Treatment of Café-au-Lait Macules (CALMs): A randomized, split-lesion clinical trial. Lasers in Surgery and Medicine, 2021; 53(4):435–442.
2.
Kanchanapoomi LevinM, NgE, BaeY-SC, et al.Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review. Lasers Surg Med, 2016; 48(2):181–187.
3.
YuW, ZhuJ, YuW, et al.A split-face, single-blinded, randomized controlled comparison of alexandrite 755-nm picosecond laser versus alexandrite 755-nm nanosecond laser in the treatment of acquired bilateral nevus of Ota-like macules. J Am Acad Dermatol, 2018; 79(3):479–486.
4.
AurangabadkarSJ. Optimizing Q-switched lasers for melasma and acquired dermal melanoses. Indian J Dermatol Venereol Leprol, 2019; 85(1):10–17.
5.
NisticoSP, SilvestriM, ZingoniT, et al.Combination of fractional CO2 laser and Rhodamine-Intense pulsed light in facial rejuvenation: A randomized controlled trial. Photobiomodul Photomed Laser Surg, 2021; 39(2):113–117.
6.
LodiG, SanninoM, CaterinoP, et al.Fractional CO2 laser-assisted topical rifamycin drug delivery in the treatment of pediatric cutaneous leishmaniasis. Pediatr Dermatol, 2021; 38(3):717–720.
7.
MercuriSR, BriantiP, DattolaA, et al.CO2 laser and photodynamic therapy: Study of efficacy in periocular BCC. Dermatol Ther, 2018; 31(4):e12616.
8.
CannarozzoG, BennardoL, NegosantiF, et al.CO2 laser treatment in idiopathic scrotal calcinosis: A case series. J Lasers Med Sci, 2020; 11(4):500–501.
9.
FabiSG, FriedmannDP, Niwa MassakiAB, et al.A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Lasers Surg Med, 2014; 46(7):531–537.
10.
VachiramonV, McMichaelAJ. Approaches to the evaluation of lip hyperpigmentation. Int J Dermatol, 2012; 51(7):761–770.
11.
KurniadiI, TabriF, MadjidA, et al.Laser tattoo removal: Fundamental principles and practical approach. Dermatol Ther, 2021; 34(1):e14418.
12.
JenzerAC, StorrsBP, DanielsZ, HanlonJJ. Traumatic facial tattoo injuries from gunpowder and ammunition: A case series. Craniomaxillofac Trauma Reconstr, 2020; 13(2):133–137.
Kuperman-BeadeM, LevineVJ, AshinoffR. Laser removal of tattoos. Am J Clin Dermatol, 2001; 2(1):21–25.
15.
AmburAB, KhalidM, KhanL, NathooR. Traumatic tattooing: Case description and a comprehensive review of the therapeutic management. J Osteopath Med, 2024; 124(4):183–185.
16.
FusadeT, ToubelG, GrognardC, MazerJM. Treatment of gunpowder traumatic tattoo by Q-switched Nd:YAG laser: An unusual adverse effect. Dermatol Surg, 2000; 26(11):1057–1059.
17.
SiemersF, StangFH, NamdarT, et al.Removal of accidental inclusions following blast injury by use of a hydrosurgery system (VersajetTM). Injury Extra, 2010; 41(8):83–84.
18.
SeitzA-T, GrunewaldS, WagnerJA, et al.Fractional CO2 laser is as effective as Q-switched ruby laser for the initial treatment of a traumatic tattoo. J Cosmet Laser Ther, 2014; 16(6):303–305.
19.
QuY, WangL, ZhouP, ZhangW. Efficient picosecond laser for tattoo removal in rat models. Med Sci Monit, 2020; 26:e924583-1.
20.
LaubDR, YulesRB, ArrasM, et al.Preliminary histopathological observation of Q-switched ruby laser radiation on dermal tattoo pigment in man. J Surg Res, 1968; 8(5):220–224.
21.
KimM, ParkS, LeeHU, KangHW. Quantitative monitoring of tattoo contrast variations after 755-nm laser treatments in in vivo tattoo models. Sensors (Basel), 2020; 20(1):285.
22.
LajevardiV, MahmoudiH, KarimiF, et al.Comparing QS Nd:YAG laser alone with its combination with fractional ablative Er:YAG in tattoo removal. J Cosmet Dermatol, 2021; 20(12):4078–4080.
23.
BennardoL, CannarozzoG, TamburiF, et al.Picosecond Q-Switched 1064/532 nm laser in tattoo removal: Our single center experience. Applied Sciences, 2021; 11(20):9712.
24.
KaminerMS, CapelliCC, SadeghpourM, et al.Increased tattoo fading in a single laser tattoo removal session enabled by a rapid acoustic pulse device: A prospective clinical trial. Lasers Surg Med, 2020; 52(1):70–76.
25.
El-DomyatiM, HosamW, NasifG, et al.Tattoo removal by Q-switched Nd:YAG laser: An objective evaluation using histometry. J Cosmet Laser Ther, 2019; 21(6):328–331.
26.
MartinsA, TrindadeF, LeiteL. Facial scars after a road accident–combined treatment with pulsed dye laser and Q-switched Nd:YAG laser. J Cosmet Dermatol, 2008; 7(3):227–229.
27.
BonanP, BassiA, BruscinoN, et al.Combined pulsed dye laser and Q-switched Nd:YAG laser intraumatic facial tattoo removal: A case series. Dermatol Ther, 2019; 32(5):e13069.
28.
GorouhiF, DavariP, KashaniMN, FiroozA. Treatment of traumatic tattoo with the Q‐switched Nd:YAG laser. J Cosmet Laser Ther, 2007; 9(4):253–255.
29.
UlrichF, ElahiL, Alexander RossiS, et al.Outcome after treatment with 15% Trichloroacetic acid peeling after facial black powder injury. Aesthet Surg J Open Forum, 2022; 4:ojac056.
30.
YangQ, XueP, FanX, et al.Lasers treatment for traumatic facial tattoo. Lasers Med Sci, 2022; 38(1):28.
31.
SilvestriM, BennardoL, ZappiaE, et al.Q-Switched 1064/532 nm laser with picosecond pulse to treat benign hyperpigmentations: A single-center retrospective study. Applied Sciences, 2021; 11(16):7478.
32.
NastA, GauglitzG, LorenzK, et al.S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids) – Update 2020. J Dtsch Dermatol Ges, 2021; 19(2):312–327.
ElsaieML, ChoudharyS. Lasers for scars: A review and evidence-based appraisal This is an updated review article discussing scar treatment with lasers with an evidence-based approach. Journal of Drugs in Dermatology: JDD, 2010; 9(11):1355–1362.
35.
BouzariN, DavisSC, NouriK. Laser treatment of keloids and hypertrophic scars. Int J Dermatol, 2007; 46(1):80–88.
36.
KuoYR, JengSF, WangFS, et al.Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta1 expression and extracellular matrix expression. Lasers Surg Med, 2004; 34(2):104–108.
37.
ZhiboX, MiaoboZ. Molecular mechanism of pulsed-dye laser in treatment of keloids: An in vitro study. Adv Skin Wound Care, 2010; 23(1):29–33.
38.
ZeikusPS. Principles and practices in cutaneous laser surgery. J Am Acad Dermatol, 2006; 55(1):181.
39.
ManuskiattiW, WanitphakdeedechaR, FitzpatrickRE. Effect of pulse width of a 595-nm flashlamp-pumped pulsed dye laser on the treatment response of keloidal and hypertrophic sternotomy scars. Dermatol Surg, 2007; 33(2):152–161.
40.
TanziEL, AlsterTS. Laser treatment of scars. Skin Therapy Lett, 2004; 9(1):4–7.
41.
AtiyehBS. Nonsurgical management of hypertrophic scars: Evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg, 2007; 31(5):468–492.
42.
ChoSB, LeeSJ, ChungWS, et al.Treatment of burn scar using a carbon dioxide fractional laser. J Drugs Dermatol, 2010; 9(2):173–175.
43.
CastroDJ, AbergelRP, MeekerC, et al.Effects of the Nd:YAG laser on DNA synthesis and collagen production in human skin fibroblast cultures. Ann Plast Surg, 1983; 11(3):214–222.
44.
BowesLE, NouriK, BermanB, et al.Treatment of pigmented hypertrophic scars with the 585nm pulsed dye and the 532nm frequency-doubled Nd:YAG laser in the Q-switchedand variable pulse modes: A comparative study. Dermatol Surg, 2002; 28:714–719.
45.
PasseronT, GenedyR, SalahL, et al.Laser treatment of hyperpigmented lesions: Position statement of the European Society of Laser in Dermatology. Eur Acad Dermatol Venereol, 2019; 33(6):987–1005; doi: 10.1111/jdv.15497
46.
PaaschU, ZidaneM, BaronJM, et al.S2k guideline: Laser therapy of the skin. J Dtsch Dermatol Ges, 2022; 20(9):1248–1267; doi: 10.1111/ddg.14879
47.
AndersonRR, MargolisRJ, WatenabeS, FlotteT, HruzaGJ, DoverJS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol., 1989; 93(1):28–32; doi: 10.1111/1523-1747.ep12277339
48.
PaaschU. Fraktionale laser: Wunsch und Wirklichkeit. Akt Dermatol, 2013; 39(07):257–262.
49.
WangCC, HuangCL, SueYM, et al.Treatment of cosmetic tattoos using carbon dioxide ablative fractional resurfacing in an animal model: A novel method confirmed histopathologically. Dermatol Surg, 2013; 39(4):571–577.
50.
IbrahimiOA, SyedZ, SakamotoFH, et al.Treatment of tattoo allergy with ablative fractional resurfacing: A novel paradigm for tattoo removal. J Am Acad Dermatol., 2011; 64(6):1111–1114.
51.
GurnaniP, WilliamsN, Al-HetheliGC, et al.Comparing the efficacy and safety of laser treatments in tattoo removal: A systematic review. J Am Acad Dermatol, 2022; 87(1):103–109.
52.
PiccoloD, CrismanG, ConfortiC, FuscoI, BonanP. Efficacy of a multimodal approach of laser therapy for earlobe keloids management in dark population. Skin Res Technol, 2023; 29(11):e13502; doi: 10.1111/srt.13502
53.
GrevelinkJM, DukeD, van LeeuwenRL, GonzalezE, DeCosteSD, AndersonRR. Laser treatment of tattoos in darkly pigmented patients: Efficacy and side effects. J Am Acad Dermatol., 1996; 34(4):653–656; doi: 10.1016/s0190-9622(96)80068-5
HarithyR, PonK. Scar treatment with lasers: A review and update. Curr Derm Rep, 2012; 1(2):69–75; doi: 10.1007/s13671-012-0009-7
57.
CannarozzoG, PennatiBM, FuscoI, et al.Multi-modal approach with dye laser and CO2 laser for the resolution of vascularized acne scars: A case series. AME Case Rep, 2025; 9:36; doi: 10.21037/acr-24-130
58.
AlsterTS, LewisAB, RosenbachA. Laser scar revision: Comparison of CO2 laser vaporization with and without simultaneous pulsed dye laser treatment. Dermatol Surg, 1998; 24(12):1299–1302; doi: 10.1111/j.1524-4725.1998.tb00003.x
59.
SongWJ, NamSM, ParkES, et al.The effectiveness of early combined CO2 ablative fractional laser and 595-nm pulsed dye laser treatment after scar revision. J Craniofac Surg, 2021; 32(2):629–631; doi: 10.1097/SCS.0000000000006983
60.
NoelaniG, GoldbergDJ. Update on the treatment of scars. J Drugs Dermatol, 2019; 18(6):550–555.
61.
RadmaneshM, GhanatirF, RadmaneshR. Comparing the efficacy of pulsed dye laser, QSwitched Nd-YAG, CO2, and combined CO2 and Q-Switched Nd-YAG lasers for the treatment of cutaneous macular amyloidosis. J Dermatolog Treat., 2021; 32(2):258–260; doi: 10.1080/09546634.2019.1654071
62.
TheodorakopoulouE, AguileraSB, DuncanDI. A new therapeutic approach with rose stem-cell-derived exosomes and non-thermal microneedling for the treatment of facial pigmentation. Aesthet Surg J Open Forum, 2024; 6:ojae060; doi: 10.1093/asjof/ojae060
63.
AmatoS, NisticòSP, ClementiA, et al.Multispectral imaging and OCT-Guided precision treatment of rhinophyma with CO2 and dye lasers: A comprehensive diagnostic and therapeutic approach. Cosmetics, 2024; 11(6):221; doi: 10.3390/cosmetics11060221
